EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GPR97–Gα12–mTORC1 signaling drives myotube hypertrophy: identification of 5-hydroxy-7-methoxyflavone as a pathway activator

Shuhei Fujita, Ayano Kimura, Daisuke Maekawa, Mai Kubota, Tomoya Kitakaze, Naoki Goshima, Naoki Harada, Ryoichi Yamaji

Archives of Biochemistry and Biophysics · 2026

DOI: 10.1016/j.abb.2026.110964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026. Verfasst von Shuhei Fujita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka, 5998531, Japan. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Signal Transduction, Receptors, G-Protein-Coupled, Muscle Fibers, Skeletal. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elucidating novel signaling pathways that drive myotube hypertrophy may provide new insights into the mechanisms regulating skeletal muscle growth. We previously reported that 5-hydroxy-7-methoxyflavone (HMF) induces hypertrophy of murine C2C12 myotubes; however, the underlying molecular mechanism remains unclear. Here, loss- and gain-of-function analyses revealed that GPR97 positively regulates myotube size. Furthermore, knockdown and rescue experiments demonstrated that GPR97 is required for HMF-induced myotube hypertrophy. HMF activated mTORC1 signaling in myotubes, and intramuscular administration of HMF also activated mTORC1 signaling in mouse skeletal muscle in vivo. Gpr97 knockdown abolished HMF-induced mTORC1 signaling and protein synthesis. Furthermore, depletion of Gna12 and expression of dominant-negative Gα12 abolished HMF-induced myotube hypertrophy. Gna12 depletion also suppressed HMF-induced mTORC1 signaling and protein synthesis. Beclomethasone dipropionate, a reported GPR97 ligand, suppressed HMF-induced hypertrophy and mTORC1 signaling, while further enhancing HMF-induced serum response factor (SRF)-dependent transcription. Although dominant-negative RhoA inhibited HMF-induced SRF-dependent transcriptional activity, it did not affect myotube hypertrophy. These findings indicate that GPR97-Gα12-mTORC1 signaling promotes hypertrophy independent of the Gα12-RhoA-SRF pathway. GPR97 was predominantly expressed on the myotube surface as a C-terminal fragment generated by N-terminal fragment (NTF) cleavage, and HMF reduced its surface expression. HMF induced hypertrophy in myotubes expressing an NTF cleavage-resistant GPR97 mutant, but not in those expressing an NTF-deleted mutant. These results indicate that NTF cleavage is dispensable and suggest that NTF contributes to GPR97-mediated hypertrophic signaling. These findings identify a novel GPR97-Gα12-mTORC1 signaling axis that mediates HMF-induced myotube hypertrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Signal TransductionReceptors, G-Protein-CoupledMuscle Fibers, SkeletalFlavonoidsGTP-Binding Protein alpha Subunits, G12-G13AnimalsMiceHypertrophyCell Line

Stichwörter der Autor:innen

5-Hydroxy-7-methoxyflavoneG protein-coupled receptor 97Gα12RhoAmTORC1myotube hypertrophy

Substanzen

Mechanistic Target of Rapamycin Complex 1Receptors, G-Protein-CoupledFlavonoidsGTP-Binding Protein alpha Subunits, G12-G13Adgrg1 protein, mouse

Autor:innen und Institutionen

  • Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka, 5998531, Japan.
  • Division of Applied Life Sciences, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Sakai, Osaka, 5998531, Japan.
  • Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka, 5998531, Japan; Division of Applied Life Sciences, Graduate School of Life and Environmental Scien…
  • Molecular Profiling Research Center for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Koto-ku, Tokyo, 1350064, Japan; Department of Human Sciences, Musashino University, Koto-ku, Toky…

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Fujita, S., Kimura, A., Maekawa, D., Kubota, M., Kitakaze, T., Goshima, N., Harada, N., & Yamaji, R. (2026). GPR97–Gα12–mTORC1 signaling drives myotube hypertrophy: identification of 5-hydroxy-7-methoxyflavone as a pathway activator. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2026.110964

Vancouver

Fujita S, Kimura A, Maekawa D, Kubota M, Kitakaze T, Goshima N, et al. GPR97–Gα12–mTORC1 signaling drives myotube hypertrophy: identification of 5-hydroxy-7-methoxyflavone as a pathway activator. Archives of Biochemistry and Biophysics. 2026. doi:10.1016/j.abb.2026.110964

BibTeX
@article{Fujita2026,
  author = {Fujita, Shuhei and Kimura, Ayano and Maekawa, Daisuke and Kubota, Mai and Kitakaze, Tomoya and Goshima, Naoki and Harada, Naoki and Yamaji, Ryoichi},
  title = {GPR97–Gα12–mTORC1 signaling drives myotube hypertrophy: identification of 5-hydroxy-7-methoxyflavone as a pathway activator},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2026},
  doi = {10.1016/j.abb.2026.110964}
}
Kostenlos starten →